Since its discovery in the early 1990s, BPC-157 has been studied extensively in laboratory and animal models for its potential influence on cellular protection, structural repair, and angiogenic processes
In research communities, these peptides are often discussed as complementary rather than directly competitive because: GHK-Cu is often chosen for collagen, skin, scar, and cosmetic tissue remodeling goals BPC-157 is often chosen for tendon, ligament, joint, muscle, and deeper recovery goals For that reason, many researchers discussing GHK-Cu vs BPC-157 eventually decide the better question is not which one is better, but which one better matches the tissue target? If you are building a broader research setup, you may also want to browse our research peptide collection for compatible inventory planning
Supplied in 30mL vials providing sufficient volume for repeated in vitro assay preparation
doi: 10.3390/medicina61020291